HUT61664A - Process for producing pharmaceutical composition for treating malaria - Google Patents

Process for producing pharmaceutical composition for treating malaria

Info

Publication number
HUT61664A
HUT61664A HU921528A HU9201528A HUT61664A HU T61664 A HUT61664 A HU T61664A HU 921528 A HU921528 A HU 921528A HU 9201528 A HU9201528 A HU 9201528A HU T61664 A HUT61664 A HU T61664A
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
producing pharmaceutical
treating malaria
malaria
treating
Prior art date
Application number
HU921528A
Other languages
English (en)
Other versions
HU227345B1 (en
HU9201528D0 (en
Inventor
Yiqing Zhou
Dianxi Ning
Shufen Wang
Deben Ding
Guofu Li
Chengqi Shan
Guangyu Liu
Original Assignee
Ciba Geigy Ag
Inst Microbiology & Epidemiology Academy Military Medical Sciences Pla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25742651&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT61664(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag, Inst Microbiology & Epidemiology Academy Military Medical Sciences Pla filed Critical Ciba Geigy Ag
Publication of HU9201528D0 publication Critical patent/HU9201528D0/hu
Publication of HUT61664A publication Critical patent/HUT61664A/hu
Publication of HU227345B1 publication Critical patent/HU227345B1/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HU9201528A 1990-08-08 1991-06-05 Synergetic antimalarial pharmaceutical compositions HU227345B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN90106722A CN1058717A (zh) 1990-08-08 1990-08-08 抗疟新药—复方蒿甲醚及其制备方法
CN91102575A CN1085527C (zh) 1990-08-08 1991-04-24 增效复方抗疟药本芴醇的制备方法
PCT/EP1991/001033 WO1992002217A1 (en) 1990-08-08 1991-06-05 Antimalarial compositions

Publications (3)

Publication Number Publication Date
HU9201528D0 HU9201528D0 (en) 1992-08-28
HUT61664A true HUT61664A (en) 1993-03-01
HU227345B1 HU227345B1 (en) 2011-04-28

Family

ID=25742651

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9201528A HU227345B1 (en) 1990-08-08 1991-06-05 Synergetic antimalarial pharmaceutical compositions

Country Status (27)

Country Link
US (1) US5677331A (hu)
EP (1) EP0500823B1 (hu)
JP (1) JP2562857B2 (hu)
KR (1) KR100221689B1 (hu)
CN (2) CN1058717A (hu)
AP (1) AP231A (hu)
AT (1) ATE135209T1 (hu)
AU (1) AU642747B2 (hu)
CA (1) CA2065285C (hu)
DE (2) DE10199038I2 (hu)
DK (1) DK0500823T3 (hu)
EG (1) EG19905A (hu)
ES (1) ES2084168T3 (hu)
FI (1) FI921491A0 (hu)
GR (1) GR3019313T3 (hu)
HK (1) HK1000312A1 (hu)
HU (1) HU227345B1 (hu)
IE (1) IE72095B1 (hu)
IL (1) IL98463A (hu)
LU (1) LU90844I2 (hu)
MA (1) MA22176A1 (hu)
NL (1) NL300048I2 (hu)
NZ (1) NZ238477A (hu)
PT (1) PT97945B (hu)
SA (1) SA91120263B1 (hu)
WO (1) WO1992002217A1 (hu)
ZA (1) ZA914490B (hu)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637594A (en) * 1991-04-11 1997-06-10 Ciba Geigy Corporation Antimalarial synergistic compositions containing benflumetol
JP3560970B2 (ja) * 1992-02-07 2004-09-02 ノバルティス アクチェンゲゼルシャフト ベンゾフルメトールを含有する抗マラリア性の相乗作用組成物
WO1995027964A1 (en) * 1994-04-12 1995-10-19 Qualcomm Incorporated Method and apparatus for freight transportation using a satellite navigation system
US5657088A (en) * 1995-12-22 1997-08-12 Cirrus Logic, Inc. System and method for extracting caption teletext information from a video signal
US6136847A (en) * 1996-12-02 2000-10-24 Johns Hopkins University Water-soluble trioxanes as potent and safe antimalarial agents
CH692321A5 (de) 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
CO5040050A1 (es) 1998-06-25 2001-05-29 Novartis Ag Compuestos de 2-amino-1-(9-arilmetilidina-2,7-dicloro-9h- fluoren-4-ilo)-etanoles n-sustituidos, procedimientos para su obtencion y preparados farmaceuticos que los contienen .
IN191696B (hu) * 1999-02-12 2003-12-20 Council Scient Ind Res
EP1267864A1 (en) * 2000-03-31 2003-01-02 Council Of Scientific & Industrial Research A synergistic anti-malarial formulation
JPWO2002032905A1 (ja) * 2000-10-20 2004-02-26 味の素株式会社 マラリア治療のための医薬組成物、ドーズおよび方法
US7842719B2 (en) * 2002-10-31 2010-11-30 Kemin Foods, L.C. Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus
WO2004075817A2 (en) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Suspendable pharmaceutical composition
ZA200602031B (en) * 2003-09-04 2007-05-30 Cipla Ltd Antimalarial compositions and process thereof
US20110206636A1 (en) * 2003-09-16 2011-08-25 Kemin Foods, LLC Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever Virus
WO2007017646A2 (en) * 2005-08-05 2007-02-15 Cipla Limited Anti-malarial composition comprising artesunate and lumefantrine
WO2007036947A1 (en) * 2005-09-30 2007-04-05 Ipca Laboratories Limited Delayed release anti-malarial composition
US20090324715A1 (en) * 2006-06-26 2009-12-31 Sumit Madan High dose oral pharmaceutical compositions of artemether and lumefantrine
CN100463669C (zh) * 2006-08-31 2009-02-25 广州市医药工业研究所 复方蒿甲醚自乳化剂
WO2008098586A1 (en) * 2007-02-13 2008-08-21 Dafra Pharma N.V. Pharmaceutical carrier composition and pharmaceutical composition
CH700941B1 (de) * 2007-12-04 2010-11-15 Mepha Ag Pharmazeutische Zusammensetzung zur Behandlung von Malaria.
FR2926993B1 (fr) * 2008-02-06 2011-03-11 Sanofi Aventis Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
WO2010004573A1 (en) * 2008-07-07 2010-01-14 Ipca Laboratories Limited Synergistic antimalarial pharmaceutical composition
WO2013143823A1 (en) * 2012-03-30 2013-10-03 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Improved rolling compound powders for applying on the surface of chewing gum core materials
CN103251584A (zh) * 2013-05-09 2013-08-21 西安力邦制药有限公司 注射用蒿甲醚/本芴醇复方脂肪乳的制备及其在疟疾治疗中的应用
WO2015140709A1 (en) * 2014-03-19 2015-09-24 Novartis Ag Solid pharmaceutical dosage forms
JP7377717B2 (ja) 2017-04-24 2023-11-10 ノバルティス アーゲー 2-アミノ-l-(2-(4-フルオロフェニル)-3-(4-フルオロフェニルアミノ)-8,8-ジメチル-5,6-ジヒドロイミダゾ[1,2-a]ピラジン-7(8h)-イル)エタノン及びそれらの組み合わせの治療レジメン
CN113599382B (zh) * 2021-08-20 2023-01-03 兰州大学 喹啉类衍生物在制备治疗糖尿病及其并发症药物中的应用
CN116747218B (zh) * 2023-08-21 2023-10-31 山东省中医药研究院 百秋李醇、百秋李醇复合抗疟组合物及制备抗疟原虫药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN85100978A (zh) * 1985-04-01 1986-08-13 中医研究院中药研究所 还原青蒿素的生产工艺
CN85100781B (zh) * 1985-04-01 1988-07-06 广西壮族自治区桂林制药厂 抗疟药物青蒿酯的制备方法
CN87101346A (zh) * 1987-06-09 1988-03-09 山东省中医药研究所 青蒿素提取工艺
DE68906345T2 (de) * 1988-10-07 1993-10-28 Hoechst Ag Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten.
CN1029680C (zh) * 1988-11-10 1995-09-06 军事医学科学院微生物流行病研究所 抗疟新药苯芴醇的合成新工艺

Also Published As

Publication number Publication date
GR3019313T3 (en) 1996-06-30
FI921491A (fi) 1992-04-03
WO1992002217A1 (en) 1992-02-20
EP0500823B1 (en) 1996-03-13
CN1065993A (zh) 1992-11-11
DE10199038I2 (de) 2007-01-04
JP2562857B2 (ja) 1996-12-11
EG19905A (en) 1996-05-31
IL98463A (en) 1995-10-31
ES2084168T3 (es) 1996-05-01
ATE135209T1 (de) 1996-03-15
DE69117922T2 (de) 1996-09-05
FI921491A0 (fi) 1992-04-03
SA91120263B1 (ar) 2004-08-31
DK0500823T3 (da) 1996-04-01
CN1058717A (zh) 1992-02-19
HU227345B1 (en) 2011-04-28
AU7954991A (en) 1992-03-02
CA2065285A1 (en) 1992-02-09
CN1085527C (zh) 2002-05-29
NZ238477A (en) 1992-12-23
PT97945B (pt) 1998-11-30
NL300048I2 (nl) 2002-03-01
NL300048I1 (nl) 2001-10-01
KR920702217A (ko) 1992-09-03
ZA914490B (en) 1992-03-25
PT97945A (pt) 1992-04-30
IL98463A0 (en) 1992-07-15
AP231A (en) 1993-01-31
IE911989A1 (en) 1992-02-12
IE72095B1 (en) 1997-03-12
DE10199038I1 (de) 2001-11-22
MA22176A1 (fr) 1991-12-31
US5677331A (en) 1997-10-14
EP0500823A1 (en) 1992-09-02
JPH05501568A (ja) 1993-03-25
AP9100275A0 (en) 1991-07-31
HU9201528D0 (en) 1992-08-28
DE69117922D1 (de) 1996-04-18
CA2065285C (en) 2000-05-09
KR100221689B1 (ko) 1999-09-15
HK1000312A1 (en) 1998-02-27
LU90844I2 (fr) 2002-01-24
AU642747B2 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
HUT61664A (en) Process for producing pharmaceutical composition for treating malaria
HUT61600A (en) Process for producing l-triptophane
HU9400413D0 (en) Imidazoly-alcenoic acids, pharmaceutical compositions containing them, and process for producing them
HUT63408A (en) Process for producing omeprazole
HUT59834A (en) Process for producing stabile parenteral pharmaceutical compositions
HUT54046A (en) Process for producing pharmaceutical compositions
HUT60784A (en) Process for producing n,o-sulfated heparosanes and pharmaceutical compositions comprising such compounds
HUT56825A (en) Process for producing substituted 2-chloropyridines
HUT59819A (en) Process for producing stabilized pharmaceutical compositions
HUT59695A (en) Process for producing hydroxy-ethyl-amine- and norstai
HUT61548A (en) Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds
HUT61201A (en) Process for producing pharmaceutical compositions suitable for treating dermatitis
HUT58785A (en) Process for producing hypoallergene moth-oils
HUT62472A (en) Process for producing locqlly applicable pharmaceutically compositions
HUT58699A (en) Process for producing 2-chloro-5-methyl-pyridine
HUT56264A (en) Process for producing pharmaceutical compositions for external application
HUT58522A (en) Process for producing pharmaceutical compositions suitable for treating allergic conjunctivitis
HU907129D0 (en) Process for producing pharmaceutical preparatives
HUT60239A (en) Process for producing glian
HU910578D0 (en) Process for producing 4-hydroxiphenethyl-alcohol
HUT61530A (en) Process for producing 1-hydroxyalkyl-5-nitroimidazoles
HU910745D0 (en) Process for producing 1-treonine
HUT55636A (en) Process for producing pharmaceutical composition
HU910729D0 (en) Process for producing pharmaceutical preparatives of anti-progestomime effect
HU207801B (en) Process for producing pharmaceutical composition for treating psoriasis

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: NOVARTIS AG., CH

Owner name: INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY, AKADEM